ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,178.66
-0.88%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Okyo Pharma Limited (OKYO)

  7. Okyo Pharma Limited (OKYO) Noticias

OKYO Okyo Pharma Limited

91.00
0.00 (0.00%)
25 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Okyo Pharma Limited OKYO London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 91.00 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
91.00 91.00
más cotizaciones de acciones »
Sector Industrial de la empresa
MINING

Noticias Recientes

Fecha Hora Fuente Noticia
08/4/202418:00UKREGOKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
02/4/202406:00UKREGOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
22/3/202406:00UKREGOKYO Pharma Announces OK-101 Successfully Achieved..
21/3/202406:00UKREGOKYO Pharma to Host Key Opinion Leader Event to Discuss New..
20/3/202406:00UKREGOKYO Pharma to Release New and Comprehensive Data from Phase..
09/2/202406:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
09/2/202406:00UKREGOKYO Pharma Receives FDA Approval of IND for OK-101 in..
31/1/202406:00UKREGOKYO Pharma Announces Distinguished Ophthalmologists with..
08/1/202406:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
05/1/202408:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
04/12/202306:00GLOBEOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
31/10/202306:00GLOBEOKYO Pharma Announces $5.84 Million Cash Raise and Payables..
09/10/202306:00GLOBEOKYO Pharma Announces Filing of an Investigational New Drug..
05/10/202306:00GLOBEOKYO Pharma Announces Positive Safety Data Profile for the..
15/9/202306:00GLOBEOKYO Pharma Announces Closing of $4.0 Million Registered..
14/9/202308:15GLOBEOKYO Pharma Announces Pricing of $4.0 Million Registered..
14/9/202307:45GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
13/9/202315:05GLOBEOKYO Pharma Announces Public Offering of Ordinary Shares
08/9/202306:00GLOBEOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
30/8/202306:00GLOBEOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
29/8/202306:00GLOBEOKYO Pharma Limited Regains Compliance with Nasdaq Listing..
15/8/202308:00GLOBEOKYO Pharma Limited Reports Annual Results for the Twelve..
31/7/202301:18GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
28/7/202316:25GLOBEOKYO Pharma Announces Proposed Public Offering of Ordinary..
28/7/202316:05GLOBEOKYO Pharma Limited Receives Nasdaq Deficiency Notice
28/7/202306:01GLOBEOKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in..
27/7/202310:30GLOBEOKYO Pharma Announces Appointment of William A. Clementi as..
06/6/202308:30GLOBEOKYO Pharma Announces Randomized Segment Now Underway in..
22/5/202302:15UKREGOKYO Pharma Limited London Stock Exchange Delisting
22/5/202302:00UKREGLondon Stock Exchange Notice Cancellation - OKYO PHARMA..
19/5/202305:22ALNCNewsIN BRIEF: Okyo Pharma to move shares to New York with London..
19/5/202302:00RNSNONOKYO Pharma Limited ADS Program collapse
15/5/202301:00UKREGOKYO Pharma Limited Change of Record Time and Last Day of..
11/5/202308:27ALNCNewsIN BRIEF: Okyo Pharma delays delisting from London trading..
11/5/202306:00RNSNONOKYO Pharma Limited Webull Corporate Communications Service..
11/5/202301:00UKREGOKYO Pharma Limited Change of Delisting Date to 22 May 2023
03/5/202307:00UKREGOKYO Pharma Limited Result of Meeting
03/5/202301:00GLOBEOKYO Pharma Announces Presentations at the American Society..
02/5/202314:16ALNCNewsTRADING UPDATES: Knights Group buys St James Law and Baines..
02/5/202301:00GLOBEOKYO Pharma Announces First-Patient First-Visit for Phase 2..
02/5/202301:00UKREGOKYO Pharma Limited First-Patient First-Visit for Phase 2..

Su Consulta Reciente

LSE
OKYO
Okyo Pharma
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados